1. Home
  2. PTCT vs BFAM Comparison

PTCT vs BFAM Comparison

Compare PTCT & BFAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • BFAM
  • Stock Information
  • Founded
  • PTCT 1998
  • BFAM 1986
  • Country
  • PTCT United States
  • BFAM United States
  • Employees
  • PTCT N/A
  • BFAM N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • BFAM Other Consumer Services
  • Sector
  • PTCT Health Care
  • BFAM Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • BFAM Nasdaq
  • Market Cap
  • PTCT 5.3B
  • BFAM 5.7B
  • IPO Year
  • PTCT 2013
  • BFAM 1997
  • Fundamental
  • Price
  • PTCT $75.70
  • BFAM $99.76
  • Analyst Decision
  • PTCT Buy
  • BFAM Buy
  • Analyst Count
  • PTCT 17
  • BFAM 7
  • Target Price
  • PTCT $73.24
  • BFAM $132.43
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • BFAM 952.2K
  • Earning Date
  • PTCT 11-04-2025
  • BFAM 10-30-2025
  • Dividend Yield
  • PTCT N/A
  • BFAM N/A
  • EPS Growth
  • PTCT N/A
  • BFAM 72.95
  • EPS
  • PTCT 8.94
  • BFAM 3.47
  • Revenue
  • PTCT $1,779,150,000.00
  • BFAM $2,874,055,000.00
  • Revenue This Year
  • PTCT $119.02
  • BFAM $11.17
  • Revenue Next Year
  • PTCT N/A
  • BFAM $6.93
  • P/E Ratio
  • PTCT $8.42
  • BFAM $28.71
  • Revenue Growth
  • PTCT 97.54
  • BFAM 9.38
  • 52 Week Low
  • PTCT $35.95
  • BFAM $91.49
  • 52 Week High
  • PTCT $76.80
  • BFAM $132.99
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 79.67
  • BFAM 47.08
  • Support Level
  • PTCT $69.23
  • BFAM $95.87
  • Resistance Level
  • PTCT $73.98
  • BFAM $101.94
  • Average True Range (ATR)
  • PTCT 2.67
  • BFAM 3.36
  • MACD
  • PTCT 0.40
  • BFAM 0.37
  • Stochastic Oscillator
  • PTCT 89.08
  • BFAM 45.37

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About BFAM Bright Horizons Family Solutions Inc.

Bright Horizons Family Solutions Inc provider of early education and child care, family care solutions, and workforce education services that help working families and client employees personally and professionally. It provides services under multi-year contracts with employers that offer early education and child care, back-up care, and educational advisory services as part of their employee benefits package. The company has three business segments; full-service center-based child care, backup care, and educational advisory services. The majority of the revenue is generated by full-service center-based child care, which includes traditional center-based child care and early education services. Other services provided by the company include in-home child and elder care, and Others.

Share on Social Networks: